| GTO ID | GTC0749 |
| Trial ID | ChiCTR1800017425 |
| Disease | Acute Leukemia |
| Therapy | CAR-T cell |
| Treatment | Donor lymphocyte infusion |
| Recruitment status | Recruiting |
| Title | Chimeric Antigen Receptor–Modified T Cells combined with donor lymphocyte infusion or tyrosine kinase inhibitors to treat the acute lymphoblastic leukemia patients who experienced relapse after allogeneic hematopoietic stem cell transplantation |
| Year | 2018 |
| Country | China |
| Company sponsor | Peking University People's Hospital |
| Cohort 1 | |||||||
|
|||||||